Zobrazeno 1 - 10
of 68
pro vyhledávání: '"subcutaneous drug administration"'
Autor:
Gabriel A. Aguirre, LA Morales, R. G. de la Garza, Mariano García-Magariño, Inma Castilla-Cortázar, Irene Martín-Estal, Víctor Javier Lara-Díaz, Juan E. Puche, Úrsula Muñoz
Publikováno v:
Journal of Physiology and Biochemistry
Even though the liver synthesizes most of circulating IGF-1, it lacks its receptor under physiological conditions. However, according to previous studies, a damaged liver expresses the receptor. For this reason, herein, we examine hepatic histology a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de623c80426c9703389e993d92c068c5
https://doi.org/10.1007/s13105-016-0545-x
https://doi.org/10.1007/s13105-016-0545-x
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Feline Medicine and Surgery. 11:499-502
The aim of this study was to determine the therapeutic success of the medical treatment of pyometra with the antigestagen aglepristone and to document the recurrence rate in relation to the time interval after treatment with antigestagens in cats. Te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5f33bbad8e6808a6b0a5ceb639e062e
https://doi.org/10.1016/j.jfms.2008.09.006
https://doi.org/10.1016/j.jfms.2008.09.006
Autor:
Piero Galieni, Roberto Stasi, Maria Cantonetti, Sante Tura, Giuseppe Papa, Giovani Poeta, Adriano Venditti, Vito Michele Lauta, E. Dispensa, Alessio Perrotti, Eugenio Damasio, Franco Dammacco, Pier Luigi Zinzani
Publikováno v:
Scopus-Elsevier
Serum levels of 13 different cytokines and receptors were measured serially in 78 patients with aggressive non-Hodgkin's lymphoma (NHL) treated by 4 cycles of an intensive multi-agent chemotherapy regimen. Recombinant human granulocyte-macrophage col
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6233ed6da5af1fca17d4a09e9215e39
https://doi.org/10.1111/j.1600-0609.1995.tb01619.x
https://doi.org/10.1111/j.1600-0609.1995.tb01619.x
Micro-costing study of rituximab subcutaneous injection versus intravenous infusion in dutch setting
Autor:
Mihajlović, J., Bax, P., Van Breugel, E., Blommestein, H.M., Hoogendoorn, M., Hospes, W., Postma, M.J.
Publikováno v:
Haematologica, 100. FERRATA STORTI FOUNDATION
Background: Rituximab for subcutaneous (SC) administration has recently been approved for use in common forms of diffuse large B-cell lymphoma (DLBCL). This form of rituximab is supplied in ready-to-use vials that do not require individual dose adjus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::533017c6ec6d56457da861235bade87d
https://research.rug.nl/en/publications/7c52057b-a2b3-45cf-b803-e8631f648cd3
https://research.rug.nl/en/publications/7c52057b-a2b3-45cf-b803-e8631f648cd3
Micro-costing study of rituximab subcutaneous injection versus intravenous infusion in dutch setting
Publikováno v:
Haematologica. 100
Background: Rituximab for subcutaneous (SC) administration has recently been approved for use in common forms of diffuse large B-cell lymphoma (DLBCL). This form of rituximab is supplied in ready-to-use vials that do not require individual dose adjus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::d428911b899a01d8b610db45c6aafff9
https://hdl.handle.net/11370/7c52057b-a2b3-45cf-b803-e8631f648cd3
https://hdl.handle.net/11370/7c52057b-a2b3-45cf-b803-e8631f648cd3
Publikováno v:
Human Reproduction, 6, 13, 1461-1464
The objective of this study was to compare the bioavailability of s.c. and i.m. administration of human chorionic gonadotrophin (HCG; Pregnyl). In a randomized, single-centre, three-way cross-over study, 18 healthy pituitary-suppressed volunteers wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2167266e6c8991abb62e231326b6850c
https://doi.org/10.1093/humrep/13.6.1461
https://doi.org/10.1093/humrep/13.6.1461
Autor:
Laszlo Otvos, Ilona Kovalszky, Annamaria Molino, Q. Piubello, John D. Wade, Rita Ferla, Kaushik Nama, Andras Sztodola, Mirko Riolfi, Eva Surmacz, Julia Olah
Publikováno v:
European journal of cancer (Oxford, England : 1990). 47(10)
Triple-negative breast cancers, which represent 10-20% of all mammary tumours, are characterised by the aggressive phenotype, are often found in younger women and have been associated with poor prognosis. Obesity increases the risk for triple-negativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07c0e80c9ee899cbe8dec9b34006d756
https://pubmed.ncbi.nlm.nih.gov/21353530
https://pubmed.ncbi.nlm.nih.gov/21353530
Publikováno v:
Blood. 114(22)
ALX-0681 is a humanized bivalent Nanobody®, that binds to the A1 domain of von Willebrand factor (vWF) and hence blocks its interaction with platelet receptor GPIb-IX-V. Given its mode of action, ALX-0681 could provide an alternative treatment optio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::2c83efd5bb2d26461a421c0b071b594d
https://hdl.handle.net/11370/90cee51d-e006-44f8-af79-b13f2273a959
https://hdl.handle.net/11370/90cee51d-e006-44f8-af79-b13f2273a959